ArticleBiosensors2025
Machine Learning-Driven D-Glucose Prediction Using a Novel Biosensor for Non-Invasive Diabetes Management.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A hybrid BiLSTM and rule-based system for integrated diabetes prediction and personalized guidance.PloS one · 2026Article
- The Convergence of Polymer Science and Predictive Modeling for Noninvasive Glucose Monitoring.Pharmaceutics · 2025Review
- AI-Empowered Electrochemical Sensors for Biomedical Applications: Technological Advances and Future Challenges.Biosensors · 2025Review
- MXene-Based Flexible Paper Chip for Glucose Detection in Sweat in Low-Temperature Environments.Sensors (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Developing reliable noninvasive diagnostic and monitoring systems for diabetes remains a significant challenge, especially in the e-healthcare domain, due to computational inefficiencies and limited predictive accuracy in current approaches. The current study integrates machine learning with a molecularly imprinted polymer biosensor for detecting D-glucose in the exhaled breath condensate or aerosol. Advanced models, such as Convolutional Neural Networks and Recurrent Neural Networks, were used to analyze resistance signals, while classical algorithms served as benchmarks. To address challenges like data imbalance, limited samples, and inter-sensor variability, synthetic data generation methods like Synthetic Minority Oversampling Technique and Generative Adversarial Networks were employed. This framework aims to classify clinically relevant glucose levels accurately, enabling non-invasive diabetes monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.